ECSP22059858A - Método para el tratamiento del síndrome de usher y composición del mismo - Google Patents
Método para el tratamiento del síndrome de usher y composición del mismoInfo
- Publication number
- ECSP22059858A ECSP22059858A ECSENADI202259858A ECDI202259858A ECSP22059858A EC SP22059858 A ECSP22059858 A EC SP22059858A EC SENADI202259858 A ECSENADI202259858 A EC SENADI202259858A EC DI202259858 A ECDI202259858 A EC DI202259858A EC SP22059858 A ECSP22059858 A EC SP22059858A
- Authority
- EC
- Ecuador
- Prior art keywords
- rna
- arrna
- target
- target rna
- usher syndrome
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7115—Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Abstract
Se provee un método para la edición dirigida de ARN diana que contiene una mutación G a A en un transcrito de gen USH2A con base en tecnología LEAPER, que comprende: introducir un constructo de un ARN de reclutamiento de adenosina desaminasa (arARN) para editar el ARN diana o un constructo que codifica dicho arARN en una célula, en donde el arARN comprende una secuencia de ARN complementaria que se hibrida al ARN diana, y en donde el arARN es capaz de reclutar adenosina desaminasa que actúa en el ARN (ADAR), de modo que la adenosina diana en el ARN diana es desaminada, realizando de este modo la edición in vivo de la base de A a I en el ARN de manera segura y eficaz, reparando un sitio de mutación patogénica, y logrando el propósito de tratar una enfermedad tal como el síndrome de Usher.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2019129957 | 2019-12-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP22059858A true ECSP22059858A (es) | 2022-11-30 |
Family
ID=76687119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSENADI202259858A ECSP22059858A (es) | 2019-12-30 | 2022-07-29 | Método para el tratamiento del síndrome de usher y composición del mismo |
Country Status (15)
Country | Link |
---|---|
US (1) | US20230067480A1 (es) |
EP (1) | EP4086346A4 (es) |
JP (1) | JP2023509177A (es) |
KR (1) | KR20220118512A (es) |
CN (1) | CN114829598A (es) |
AU (1) | AU2020418026A1 (es) |
BR (1) | BR112022012921A2 (es) |
CA (1) | CA3163280A1 (es) |
CO (1) | CO2022010430A2 (es) |
CR (1) | CR20220366A (es) |
EC (1) | ECSP22059858A (es) |
IL (1) | IL294260A (es) |
MX (1) | MX2022008197A (es) |
TW (1) | TW202138561A (es) |
WO (1) | WO2021136404A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112021020608A8 (pt) | 2019-04-15 | 2023-03-21 | Univ Beijing | Rna recrutador de desaminase, construção, método para editar um rna alvo em uma célula hospedeira, e, construção, composição, célula, biblioteca ou kit |
PE20220300A1 (es) | 2019-07-12 | 2022-03-09 | Univ Beijing | Edicion de acido ribonucleico (arn) dirigido aprovechando la adenosina desaminasa que actua sobre acido ribonucleico endogeno (adar) utilizando acidos ribonucleicos (arn) modificados geneticamente |
CA3159944A1 (en) | 2019-12-02 | 2021-06-10 | David HUSS | Therapeutic editing |
WO2023152371A1 (en) | 2022-02-14 | 2023-08-17 | Proqr Therapeutics Ii B.V. | Guide oligonucleotides for nucleic acid editing in the treatment of hypercholesterolemia |
WO2024013360A1 (en) | 2022-07-15 | 2024-01-18 | Proqr Therapeutics Ii B.V. | Chemically modified oligonucleotides for adar-mediated rna editing |
WO2024013361A1 (en) | 2022-07-15 | 2024-01-18 | Proqr Therapeutics Ii B.V. | Oligonucleotides for adar-mediated rna editing and use thereof |
GB202215614D0 (en) | 2022-10-21 | 2022-12-07 | Proqr Therapeutics Ii Bv | Heteroduplex rna editing oligonucleotide complexes |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD128000A1 (de) | 1976-10-19 | 1977-10-26 | Gerhard Wuerker | Steuereinrichtung fuer einen zwei hauptpumpen besitzenden hydraulischen antrieb |
EP3957735A1 (en) * | 2014-03-05 | 2022-02-23 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for treating usher syndrome and retinitis pigmentosa |
JP7043082B2 (ja) * | 2016-04-25 | 2022-03-29 | プロキューアール セラピューティクス ツー ベスローテン フェンノートシャップ | 眼疾患を処置するオリゴヌクレオチド |
GB201616202D0 (en) * | 2016-09-23 | 2016-11-09 | Proqr Therapeutics Ii Bv | Antisense oligonucleotides for the treatment of eye deisease |
JP7402163B2 (ja) * | 2017-12-21 | 2023-12-20 | クリスパー セラピューティクス アーゲー | 2a型アッシャー症候群の処置のための材料および方法 |
WO2019183641A1 (en) * | 2018-03-23 | 2019-09-26 | Massachusetts Eye And Ear Infirmary | Crispr/cas9-mediated exon-skipping approach for ush2a-associated usher syndrome |
JP7252328B2 (ja) | 2018-10-12 | 2023-04-04 | 北京大学 | Rnaを編集する方法および組成物 |
BR112021020608A8 (pt) * | 2019-04-15 | 2023-03-21 | Univ Beijing | Rna recrutador de desaminase, construção, método para editar um rna alvo em uma célula hospedeira, e, construção, composição, célula, biblioteca ou kit |
-
2020
- 2020-12-30 KR KR1020227024955A patent/KR20220118512A/ko not_active Application Discontinuation
- 2020-12-30 BR BR112022012921A patent/BR112022012921A2/pt not_active Application Discontinuation
- 2020-12-30 EP EP20909536.3A patent/EP4086346A4/en active Pending
- 2020-12-30 CR CR20220366A patent/CR20220366A/es unknown
- 2020-12-30 MX MX2022008197A patent/MX2022008197A/es unknown
- 2020-12-30 TW TW109146911A patent/TW202138561A/zh unknown
- 2020-12-30 CN CN202080086703.4A patent/CN114829598A/zh active Pending
- 2020-12-30 AU AU2020418026A patent/AU2020418026A1/en active Pending
- 2020-12-30 WO PCT/CN2020/141501 patent/WO2021136404A1/zh unknown
- 2020-12-30 US US17/790,484 patent/US20230067480A1/en active Pending
- 2020-12-30 CA CA3163280A patent/CA3163280A1/en active Pending
- 2020-12-30 IL IL294260A patent/IL294260A/en unknown
- 2020-12-30 JP JP2022540983A patent/JP2023509177A/ja active Pending
-
2022
- 2022-07-26 CO CONC2022/0010430A patent/CO2022010430A2/es unknown
- 2022-07-29 EC ECSENADI202259858A patent/ECSP22059858A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2023509177A (ja) | 2023-03-07 |
CN114829598A (zh) | 2022-07-29 |
US20230067480A1 (en) | 2023-03-02 |
BR112022012921A2 (pt) | 2022-09-06 |
WO2021136404A1 (zh) | 2021-07-08 |
AU2020418026A1 (en) | 2022-08-18 |
EP4086346A1 (en) | 2022-11-09 |
TW202138561A (zh) | 2021-10-16 |
EP4086346A4 (en) | 2024-03-20 |
MX2022008197A (es) | 2022-08-02 |
CR20220366A (es) | 2022-11-28 |
IL294260A (en) | 2022-08-01 |
CO2022010430A2 (es) | 2022-08-09 |
CA3163280A1 (en) | 2021-07-08 |
KR20220118512A (ko) | 2022-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP22059858A (es) | Método para el tratamiento del síndrome de usher y composición del mismo | |
CL2021000880A1 (es) | Métodos y composiciones para editar arn | |
EA201892810A1 (ru) | Гибридные последовательности нуклеиновых кислот для геномной инженерии | |
CO2022014527A2 (es) | Método y fármaco para tratar el síndrome de hurler | |
BR112021020608A2 (pt) | Rna recrutador de desaminase, construção, método para editar um rna alvo em uma célula hospedeira, e, construção, composição, célula, biblioteca ou kit | |
BR112021018159A2 (pt) | Método para gerar uma molécula de rna com atividade de silenciamento, célula geneticamente modificada, planta geneticamente modificada, célula vegetal, planta, semente, métodos de produção de uma planta, de tratamento de uma doença e de introdução da atividade de silenciamento | |
PE20230037A1 (es) | Metodo basado en tecnologia leaper para el tratamiento de mucopolisacaridosis ih y composicion | |
Yan et al. | The complete mitochondrial genome sequence of the western flower thrips Frankliniella occidentalis (Thysanoptera: Thripidae) contains triplicate putative control regions | |
AR114740A1 (es) | Métodos y composiciones para mejorar la solubilización del fosfato | |
AR103446A1 (es) | Método para modificar con precisión una planta a través de la expresión transitoria de genes | |
AR077809A1 (es) | Organismos homocigotas para una modificacion dirigida | |
AR047166A1 (es) | Promotor de metalotioneina de maiz | |
BR112018016278A2 (pt) | métodos e composições para aumentar a eficiência da modificação do gene direcionada usando reparação de gene mediada por oligonucleotídeo | |
AR069894A1 (es) | Plantas con mayor rendimiento produciendo un knock out (silenciamiento) en genes relacionados con la eficiencia en el uso de nitrogeno (ko nue)" | |
PH12021551241A1 (en) | Expansion of natural killer cells and ilc3 cells with novel aromatic compounds | |
BR112021014645A2 (pt) | Método de edição de genes | |
BR112021018120A2 (pt) | Métodos de produção de uma molécula de dsrna longo, de produção de uma planta tolerante ou resistente a pragas e de produção de uma planta ou célula vegetal, método para gerar uma planta tolerante, planta, célula e semente | |
CO2017009267A2 (es) | Proteína resistente a herbicidas, gen codificante, método para producir una proteína resistente a los herbicidas, método para seleccionar células vegetales transformadas y proteger las plantas del daño causado por los herbicidas | |
BR112022001230A2 (pt) | Estratégia de design de doador para edição de genoma crispr-cas9 | |
BR112019005605A2 (pt) | métodos para modificar o genoma (nuclear) de uma célula vegetal e um gene epsps endógeno ou para produzir uma célula vegetal ou para testar a eficiência de edição de genoma, bactéria, e, vetor | |
ATE482720T1 (de) | Verfahren zur herstellung von temperaturinduzierten tumorzell-lysaten zur verwendung als immunogene verbindungen | |
BR112022002889A2 (pt) | Método para tratar distrofia muscular tendo como alvo o gene lama1 | |
CN104032004B (zh) | 一种清真肉类食品的分子鉴定方法 | |
Chen et al. | Complete mitochondrial genome of the steppe ribbon racer (Psammophis lineolatus): The first representative from the snake family Psammophiidae and its phylogenetic implications | |
AR113432A1 (es) | Integración dirigida de ácidos nucleicos |